Literature DB >> 19846513

Hepatitis B virus requires intact caveolin-1 function for productive infection in HepaRG cells.

Alina Macovei1, Cristina Radulescu, Catalin Lazar, Stefana Petrescu, David Durantel, Raymond A Dwek, Nicole Zitzmann, Norica Branza Nichita.   

Abstract

Investigation of the entry pathways of hepatitis B virus (HBV), a member of the family Hepadnaviridae, has been hampered by the lack of versatile in vitro infectivity models. Most concepts of hepadnaviral infection come from the more robust duck HBV system; however, whether the two viruses use the same mechanisms to invade target cells is still a matter of controversy. In this study, we investigate the role of an important plasma membrane component, caveolin-1 (Cav-1), in HBV infection. Caveolins are the main structural components of caveolae, plasma membrane microdomains enriched in cholesterol and sphingolipids, which are involved in the endocytosis of numerous ligands and complex signaling pathways within the cell. We used the HepaRG cell line permissive for HBV infection to stably express dominant-negative Cav-1 and dynamin-2, a GTPase involved in vesicle formation at the plasma membrane and other organelles. The endocytic properties of the newly established cell lines, designated HepaRG(Cav-1), HepaRG(Cav-1Delta1-81), HepaRG(Dyn-2), and HepaRG(Dyn-2K44A), were validated using specific markers for different entry routes. The cells maintained their properties during cell culture, supported differentiation, and were permissive for HBV infection. The levels of both HBV transcripts and antigens were significantly decreased in cells expressing the mutant proteins, while viral replication was not directly affected. Chemical inhibitors that specifically inhibit clathrin-mediated endocytosis had no effect on HBV infection. We concluded that HBV requires a Cav-1-mediated entry pathway to initiate productive infection in HepaRG cells.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19846513      PMCID: PMC2798426          DOI: 10.1128/JVI.01207-09

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  36 in total

Review 1.  Caveolins, liquid-ordered domains, and signal transduction.

Authors:  E J Smart; G A Graf; M A McNiven; W C Sessa; J A Engelman; P E Scherer; T Okamoto; M P Lisanti
Journal:  Mol Cell Biol       Date:  1999-11       Impact factor: 4.272

2.  Bound simian virus 40 translocates to caveolin-enriched membrane domains, and its entry is inhibited by drugs that selectively disrupt caveolae.

Authors:  H A Anderson; Y Chen; L C Norkin
Journal:  Mol Biol Cell       Date:  1996-11       Impact factor: 4.138

Review 3.  Dynamin and its partners: a progress report.

Authors:  S L Schmid; M A McNiven; P De Camilli
Journal:  Curr Opin Cell Biol       Date:  1998-08       Impact factor: 8.382

Review 4.  Caveolae and caveolins.

Authors:  R G Parton
Journal:  Curr Opin Cell Biol       Date:  1996-08       Impact factor: 8.382

5.  De novo formation of caveolae in lymphocytes by expression of VIP21-caveolin.

Authors:  A M Fra; E Williamson; K Simons; R G Parton
Journal:  Proc Natl Acad Sci U S A       Date:  1995-09-12       Impact factor: 11.205

6.  Extraction of cholesterol with methyl-beta-cyclodextrin perturbs formation of clathrin-coated endocytic vesicles.

Authors:  S K Rodal; G Skretting; O Garred; F Vilhardt; B van Deurs; K Sandvig
Journal:  Mol Biol Cell       Date:  1999-04       Impact factor: 4.138

7.  Identification of dynamin 2, an isoform ubiquitously expressed in rat tissues.

Authors:  T A Cook; R Urrutia; M A McNiven
Journal:  Proc Natl Acad Sci U S A       Date:  1994-01-18       Impact factor: 11.205

8.  Dynamin-mediated internalization of caveolae.

Authors:  J R Henley; E W Krueger; B J Oswald; M A McNiven
Journal:  J Cell Biol       Date:  1998-04-06       Impact factor: 10.539

9.  Regulated internalization of caveolae.

Authors:  R G Parton; B Joggerst; K Simons
Journal:  J Cell Biol       Date:  1994-12       Impact factor: 10.539

10.  Filipin-dependent inhibition of cholera toxin: evidence for toxin internalization and activation through caveolae-like domains.

Authors:  P A Orlandi; P H Fishman
Journal:  J Cell Biol       Date:  1998-05-18       Impact factor: 10.539

View more
  48 in total

Review 1.  Cell Walls and the Convergent Evolution of the Viral Envelope.

Authors:  Jan P Buchmann; Edward C Holmes
Journal:  Microbiol Mol Biol Rev       Date:  2015-12       Impact factor: 11.056

Review 2.  Present and future therapies of hepatitis B: From discovery to cure.

Authors:  T Jake Liang; Timothy M Block; Brian J McMahon; Marc G Ghany; Stephan Urban; Ju-Tao Guo; Stephen Locarnini; Fabien Zoulim; Kyong-Mi Chang; Anna S Lok
Journal:  Hepatology       Date:  2015-10-27       Impact factor: 17.425

Review 3.  Host functions used by hepatitis B virus to complete its life cycle: Implications for developing host-targeting agents to treat chronic hepatitis B.

Authors:  Bidisha Mitra; Roshan J Thapa; Haitao Guo; Timothy M Block
Journal:  Antiviral Res       Date:  2018-08-24       Impact factor: 5.970

Review 4.  Current perspectives into the evaluation and management of hepatitis B: a review.

Authors:  Vignan Manne; Eric Gochanour; Kris V Kowdley
Journal:  Hepatobiliary Surg Nutr       Date:  2019-08       Impact factor: 7.293

Review 5.  The current status and future directions of hepatitis B antiviral drug discovery.

Authors:  Liudi Tang; Qiong Zhao; Shuo Wu; Junjun Cheng; Jinhong Chang; Ju-Tao Guo
Journal:  Expert Opin Drug Discov       Date:  2016-11-11       Impact factor: 6.098

6.  Rift Valley fever virus strain MP-12 enters mammalian host cells via caveola-mediated endocytosis.

Authors:  Brooke Harmon; Benjamin R Schudel; Dianna Maar; Carol Kozina; Tetsuro Ikegami; Chien-Te Kent Tseng; Oscar A Negrete
Journal:  J Virol       Date:  2012-09-19       Impact factor: 5.103

Review 7.  Importance of endocytic pathways in liver function and disease.

Authors:  Barbara Schroeder; Mark A McNiven
Journal:  Compr Physiol       Date:  2014-10       Impact factor: 9.090

Review 8.  Mechanism of Hepatitis B Virus Persistence in Hepatocytes and Its Carcinogenic Potential.

Authors:  Maura Dandri; Joerg Petersen
Journal:  Clin Infect Dis       Date:  2016-06-01       Impact factor: 9.079

9.  Regulation of hepatitis B virus infection by Rab5, Rab7, and the endolysosomal compartment.

Authors:  Alina Macovei; Catalina Petrareanu; Catalin Lazar; Paula Florian; Norica Branza-Nichita
Journal:  J Virol       Date:  2013-03-27       Impact factor: 5.103

10.  Entry of hepatitis B virus into immortalized human primary hepatocytes by clathrin-dependent endocytosis.

Authors:  Hsiu-Chen Huang; Chun-Chi Chen; Wen-Cheng Chang; Mi-Hua Tao; Cheng Huang
Journal:  J Virol       Date:  2012-06-27       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.